ES551220A0 - PROCEDURE TO LINK HISTAMINE TO A SUPPORT - Google Patents

PROCEDURE TO LINK HISTAMINE TO A SUPPORT

Info

Publication number
ES551220A0
ES551220A0 ES551220A ES551220A ES551220A0 ES 551220 A0 ES551220 A0 ES 551220A0 ES 551220 A ES551220 A ES 551220A ES 551220 A ES551220 A ES 551220A ES 551220 A0 ES551220 A0 ES 551220A0
Authority
ES
Spain
Prior art keywords
histamine
link
procedure
support
link histamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES551220A
Other languages
Spanish (es)
Other versions
ES8702369A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of ES8702369A1 publication Critical patent/ES8702369A1/en
Publication of ES551220A0 publication Critical patent/ES551220A0/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES551220A 1985-01-24 1986-01-24 Carrier-bound histamine, its manufacture and its use. Expired ES8702369A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8500339A SE8500339L (en) 1985-01-24 1985-01-24 PERSONAL HISTAMIN, ITS PREPARATION AND USE

Publications (2)

Publication Number Publication Date
ES8702369A1 ES8702369A1 (en) 1986-12-16
ES551220A0 true ES551220A0 (en) 1986-12-16

Family

ID=20358885

Family Applications (1)

Application Number Title Priority Date Filing Date
ES551220A Expired ES8702369A1 (en) 1985-01-24 1986-01-24 Carrier-bound histamine, its manufacture and its use.

Country Status (6)

Country Link
EP (1) EP0208776A1 (en)
JP (1) JPS62501560A (en)
AU (1) AU5396386A (en)
ES (1) ES8702369A1 (en)
SE (1) SE8500339L (en)
WO (1) WO1986004331A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1302919C (en) * 1985-07-03 1992-06-09 Robert T. Buckler Histamine derivatives, immunogen conjugates and antibodies raised thereto
DE4025726A1 (en) * 1990-08-14 1992-02-20 Boehringer Mannheim Gmbh DETERMINATION OF BIOGENIC AMINES

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2301532A (en) * 1938-08-18 1942-11-10 Parke Davis & Co Biological product and process of obtaining same
US2372066A (en) * 1940-12-23 1945-03-20 Parke Davis & Co Biological product and process of obtaining same
GB1341375A (en) * 1969-11-19 1973-12-19 Smith Kline French Lab Aminoalkylimidazoles and process for their production
GB1316990A (en) * 1970-09-17 1973-05-16 Roche Products Ltd Imidazolyl derivatives
US3873697A (en) * 1972-11-11 1975-03-25 Mack Chem Pharm Histamine antigen
US4016146A (en) * 1974-12-10 1977-04-05 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies, and use
DE3322117A1 (en) * 1983-06-20 1984-12-20 Diamalt AG, 8000 München METHOD FOR PRODUCING N (ARROW UP) (TAU) (ARROW UP) SUBSTITUTED HISTIDE INDIATIVATIVES, N (ARROW UP) (TAU) (ARROW UP) SUBSTITUTED HISTIDE INDIATIVES AND THEIR USE

Also Published As

Publication number Publication date
AU5396386A (en) 1986-08-13
SE8500339D0 (en) 1985-01-24
ES8702369A1 (en) 1986-12-16
EP0208776A1 (en) 1987-01-21
JPS62501560A (en) 1987-06-25
SE8500339L (en) 1986-07-25
WO1986004331A1 (en) 1986-07-31

Similar Documents

Publication Publication Date Title
MX160465A (en) IMPROVEMENTS TO METHOD TO MANUFACTURE A MARBET
ES547326A0 (en) A METHOD FOR PREPARING STEROL-LIPOSOMES
ES548135A0 (en) A PROCEDURE FOR PREPARING DIOXAPHOSPHORINANS
ES554380A0 (en) A PROCEDURE FOR PREPARING 8-PHENYLXANTINE DERIVATIVES
ES554567A0 (en) A PROCEDURE FOR PREPARING 8-AMINO-PURINE DERIVATIVES
ES551519A0 (en) A PROCEDURE FOR PREPARING ARYL-HYDROXAMATES
ES557707A0 (en) A PROCEDURE FOR PREPARING CYTOSINE DERIVATIVES
ES557006A0 (en) A METHOD FOR PREPARING 6-HYDROXY-2-ACETYLNAFTALENE
ES553909A0 (en) A REDUNDANT CLOCK COMBINER
IT1190089B (en) CHELE SHEAR
ES543929A0 (en) A PROCEDURE FOR PREPARING A P-ISONONANOYLOXIBENZENE-SULPHONATE
ES549860A0 (en) A PROCEDURE FOR PREPARING AMINOACIL-LADANOS
ES546157A0 (en) A PROCEDURE FOR PREPARING QUINOLONAS
ES542149A0 (en) A PROCEDURE FOR PREPARING HYDROXY-4-2H-1-BENZOTIOPIRAN-2-ONAS
ES544864A0 (en) A PROCEDURE FOR PREPARING 4-ACETOXI-3-HYDROXIETILAZETI-ZIN-2-ONA
ES554238A0 (en) A PROCEDURE FOR PREPARING CYCLOPENTIL-ETER DERIVATIVES
ES552617A0 (en) A PROCEDURE FOR PREPARING BENZMIDAZOLE DERIVATIVES
ES550525A0 (en) A PROCEDURE FOR PREPARING A PIRIDINYLMETI-KETONE DERIVATIVE
ES546645A0 (en) PROCEDURE TO PREPARE A PSEUDOOLIGOSACARIDO
ES551220A0 (en) PROCEDURE TO LINK HISTAMINE TO A SUPPORT
ES544381A0 (en) A PROCEDURE FOR PREPARING 5-DESOXI-L-ARABINOSE
AR241134A1 (en) A PROCEDURE FOR PREPARING W-BREASTFEEDERS
ES557568A0 (en) A PROCEDURE FOR PREPARING ETHYL-ALPHA- (1-CARBOXY-ETHYL) -AMI-NO-GAMMA-PHENYLBUTYRATE
ES541857A0 (en) A PROCEDURE TO PRODUCE OPTICALLY AC-TIVA FENYL-ALANINE
ES554201A0 (en) A PROCEDURE FOR PREPARING ETHANOBENZAZEPINES

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506